Literature DB >> 12037054

Multilocus sequence typing of Bordetella pertussis based on surface protein genes.

Inge H M van Loo1, Kees J Heuvelman, Audrey J King, Frits R Mooi.   

Abstract

Despite more than 50 years of vaccination, Bordetella pertussis has remained endemic in The Netherlands, causing epidemic outbreaks every 3 to 5 years. Strain variation may play a role in the persistence of B. pertussis and was studied by sequencing 15 genes coding for surface proteins, including genes for all five components of acellular pertussis vaccines: pertussis toxin (Ptx), pertactin (Prn), filamentous hemagglutinin, and fimbriae (Fim2 and Fim3). A low level of allelic variation was observed, confirming a recent evolutionary origin of B. pertussis. In modern isolates, polymorphism was observed only in prn, ptxS1, ptxS3, and tcfA. Polymorphism in ptxS1, ptxS3, and tcfA was used to categorize isolates in multilocus sequence types (MLSTs). Analysis of Dutch isolates from 1949 to 1999 revealed five MLSTs, which showed a highly dynamic temporal behavior. We observed significant changes in the MLSTs after the introduction of pertussis vaccination in The Netherlands. Epidemic years were found to be associated with the expansion of MLST-4 or MLST-5. MLST-5 showed a remarkable expansion from 10% in 1997 to 80% in 1999. The MLST analysis was extended to a number of widely separated geographic regions: Finland, Italy, Japan, and the United States. MLST-4 and MLST-5 were found to dominate in Italy and the United States. In Finland and Japan, MLST-3 and MLST-2, respectively, were predominant. Thus, although each region showed distinctive MLST frequencies, in three of the five regions MLST-4 and MLST-5 were predominant. These types may represent newly emerged, successful clones. The identification of highly successful clones may shed light on the question of how B. pertussis is able to maintain itself in vaccinated populations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12037054      PMCID: PMC130760          DOI: 10.1128/JCM.40.6.1994-2001.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  36 in total

Review 1.  Bacterial population genetics, evolution and epidemiology.

Authors:  B G Spratt; M C Maiden
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

2.  Multilocus sequence typing and antigen gene sequencing in the investigation of a meningococcal disease outbreak.

Authors:  I M Feavers; S J Gray; R Urwin; J E Russell; J A Bygraves; E B Kaczmarski; M C Maiden
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

3.  Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children.

Authors:  Paola Mastrantonio; Patrizia Spigaglia; Hans van Oirschot; Han G J van der Heide; Kees Heuvelman; Paola Stefanelli; Frits R Mooi
Journal:  Microbiology       Date:  1999-08       Impact factor: 2.777

Review 4.  Multilocus sequence typing.

Authors:  M C Enright; B G Spratt
Journal:  Trends Microbiol       Date:  1999-12       Impact factor: 17.079

5.  Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland.

Authors:  F R Mooi; Q He; H van Oirschot; J Mertsola
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

6.  Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996.

Authors:  D Güriş; P M Strebel; B Bardenheier; M Brennan; R Tachdjian; E Finch; M Wharton; J R Livengood
Journal:  Clin Infect Dis       Date:  1999-06       Impact factor: 9.079

7.  Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.

Authors:  J Storsaeter; H O Hallander; L Gustafsson; P Olin
Journal:  Vaccine       Date:  1998-12       Impact factor: 3.641

8.  Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data.

Authors:  H E de Melker; J F Schellekens; S E Neppelenbroek; F R Mooi; H C Rümke; M A Conyn-van Spaendonck
Journal:  Emerg Infect Dis       Date:  2000 Jul-Aug       Impact factor: 6.883

9.  Vag8, a Bordetella pertussis bvg-regulated protein.

Authors:  T M Finn; D F Amsbaugh
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

10.  Rapid molecular genetic subtyping of serotype M1 group A Streptococcus strains.

Authors:  N Hoe; K Nakashima; D Grigsby; X Pan; S J Dou; S Naidich; M Garcia; E Kahn; D Bergmire-Sweat; J M Musser
Journal:  Emerg Infect Dis       Date:  1999 Mar-Apr       Impact factor: 6.883

View more
  51 in total

1.  Reference system for characterization of Bordetella pertussis pulsed-field gel electrophoresis profiles.

Authors:  Abdolreza Advani; Declan Donnelly; Hans Hallander
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

2.  Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990s.

Authors:  Leo M Schouls; Han G J van der Heide; Luc Vauterin; Paul Vauterin; Frits R Mooi
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

3.  Simple Algorithm for Identification of Bordetella pertussis Pertactin Gene Variants.

Authors:  Gaëtan Muyldermans; Denis Piérard; Nathalie Hoebrekx; Reza Advani; Shirley Van Amersfoorth; Iris De Schutter; Oriane Soetens; Leo Eeckhout; Anne Malfroot; Sabine Lauwers
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

Review 4.  The Bordetella pertussis model of exquisite gene control by the global transcription factor BvgA.

Authors:  Kimberly B Decker; Tamara D James; Scott Stibitz; Deborah M Hinton
Journal:  Microbiology       Date:  2012-05-24       Impact factor: 2.777

5.  Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan.

Authors:  Atsuko Kodama; Kazunari Kamachi; Yoshinobu Horiuchi; Toshifumi Konda; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

6.  Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada.

Authors:  Raymond S W Tsang; Allan K H Lau; Michelle L Sill; Scott A Halperin; Paul Van Caeseele; Frances Jamieson; Irene E Martin
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

7.  Antigenic divergence of Bordetella pertussis isolates in Taiwan.

Authors:  Shu-Man Yao; Yu-Chi Lin; Chen-Ying Chou; Ying-Yan Chen; Miao-Ju Hsiao; Hour-Young Chen; Jer-Jea Yan; Hsun-Pi Su; Shu-Ying Li
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

8.  Use of monoclonal antibodies to serotype Bordetella pertussis isolates: comparison of results obtained by indirect whole-cell enzyme-linked immunosorbent assay and bacterial microagglutination methods.

Authors:  Raymond S W Tsang; Michelle L Sill; Abdolreza Advani; Dorothy Xing; Penny Newland; Hans Hallander
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

9.  Analysis of Bordetella pertussis populations in European countries with different vaccination policies.

Authors:  S C M van Amersfoorth; L M Schouls; H G J van der Heide; A Advani; H O Hallander; K Bondeson; C H W von König; M Riffelmann; C Vahrenholz; N Guiso; V Caro; E Njamkepo; Q He; J Mertsola; F R Mooi
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

10.  Antigenic divergence between Bordetella pertussis clinical isolates from Moscow, Russia, and vaccine strains.

Authors:  Olga Borisova; Svetlana Yu Kombarova; Nelli S Zakharova; Marjolein van Gent; Vladimir A Aleshkin; Isabella Mazurova; Frits R Mooi
Journal:  Clin Vaccine Immunol       Date:  2007-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.